NCT05295927 2025-02-03
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Janssen Research & Development, LLC
Phase 1 Terminated
Clinical Trials
8 trialsNCT00637832 2022-01-06
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
University of Southampton
Phase 2 Terminated
NCT01370694 2019-03-15
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT01074437 2018-10-04
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Phase 2 Terminated
NCT00562965 2018-01-09
Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
Pfizer
Phase 3 Terminated
NCT00967226 2016-02-24
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Children's National Research Institute
Phase 2 Terminated
NCT00275106 2013-07-10
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
National Cancer Institute (NCI)
Phase 3 Terminated
NCT01179490 2013-03-18
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
SymBio Pharmaceuticals
Phase 2 Terminated